Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to assess the effects of programmed exercise with or without electrical stimulation in the cardiorespiratory fitness, strength, functional capacity and agility in a group of young patients with Cystic Fibrosis: A randomized controlled trial comparing two interventions with a control group.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | No Intervention | This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle. | |
| Exercise-No NMES | Experimental | This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle. The exercise protocol includes a concurrent exercise intervention (strength training and aerobic training), 3 days a week, 60 minutes sessions. |
|
| Exercise-NMES | Experimental | This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle. The exercise protocol includes a concurrent exercise intervention (strength training and aerobic training), 3 days a week, 60 minutes sessions. Additionally, this group will receive neuromuscular electrical stimulation (NMES) concomitant to the strength training. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exercise-NMES | Behavioral | Exercise-NMES |
| |
| Exercise-No NMES |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Strength | Changes in strength will be measured using a five repetition maximum test (5RM) | Two assessment points throughout the study: baseline and 8 weeks after the intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Cardiorespiratory Fitness | Changes in cardiorespiratory fitness will be measured using a cardiopulmonary exercise test (CPET) | Two assessment points throughout the study:baseline and 8 weeks after the intervention |
| Changes in Pulmonary Function |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Margarita Perez Ruiz, MD | Universidad Europea de Madrid | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Escuela de Doctorado e Investigacion, Universidad Europea | Villaviciosa de Odón | 28670 | Spain |
Not provided
| ID | Term |
|---|---|
| D003550 | Cystic Fibrosis |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Behavioral |
Exercise-No NMES |
|
Changes in pulmonary function will be measured using Spirometry |
| Two assessment points throughout the study:baseline and 8 weeks after the intervention |
| Changes in physical activity levels | Changes in physical activity levels will be measured using Physical Activity Questionnaire for Children and Adolescents (PAC-C or PAC-A) | Two assessment points throughout the study:baseline and 8 weeks after the intervention |
| Change in quality of life | Changes in quality of life will be measures with the Cystic Fibrosis-Questionnaire-Revised (CFQ-R) | Two assessment points throughout the study:baseline and 8 weeks after the intervention |
| Food consumption frequency | The food consumption frequency will be measured using food frequency questionnaire (FFQ) | One assessment point at baseline:baseline and 8 weeks after the intervention |
| D030342 |
| Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007232 | Infant, Newborn, Diseases |